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Conclusions: Bending and lifting activities caused the most
pain and resulted in reduced activity. Patients participated and
experienced pain in activities that surgeons do not recommend.
Some recommended activities such as walking and stair climbing
caused pain. The pain pattern during activity over time appears
to differ between TKR and THR patients. This is one of the ﬁrst
studies to quantify activity levels and show a relation between
activities and pain in THR and TKR patients. Further research is
needed to explore differences between THR and TKR patients
and to establish the relations among activity, pain and need for
revision surgery.
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EFFICACY AND SAFETY OF TWICE-DAILY DOSING OF
CONTROLLED-RELEASEHYDROCODONE AND
ACETAMINOPHEN TABLETS FOR MODERATE TO
SEVERE OSTEOARTHRITIS PAIN: A PHASE 2,
RANDOMIZED, DOUBLE-BLIND,
PLACEBO-COONTROLLED STUDY
L. Gilderman1, J. Box2, B. Rankin3, G. Podolsky4, D. Morris5,
J. Thomas6, E. Lockhart6, R. Jain6
1University Clinical Research, Pembroke Pines, FL; 2Arthritis
Clinic and Carolina Bone and Joint, Charlotte, NC; 3University
Clinical Research, Deland, FL; 4Jean Brown Research, Salt
Lake City, UT; 5Crossroads Research, Inc. Owings Mill,
Pembroke Pines, FL; 6Abbott Laboratories, Abbott Park, IL
Purpose: To evaluate the efﬁcacy and safety of extended-release
hydrocodone/acetaminophen (HC/APAP CR) tablet (15/500 mg)
for the management of moderate to severe osteoarthritis (OA)
pain.
Methods: This Phase 2, randomized, multicenter, double-blind,
placebo-controlled study comprised 5 periods: 3-week screen-
ing/washout, 1-week titration (1 tablet twice daily), 3-week main-
tenance (2 tablets twice daily), 1-week study drug taper (1 tablet
twice daily), 1-week Follow-Up. The primary efﬁcacy endpoint
was change in patient assessment of OA pain by visual analog
scale (VAS) (0-100 mm) from baseline to ﬁnal evaluation at the
end of the maintenance period.
Results: 120 patients received at least 1 dose of study drug
and were the intent-to-treat dataset (n=58 HC/APAP CR, n=62
placebo). Most patients were white (79%) and female (72%) with
a mean age of 57 years; no statistically signiﬁcant differences
were found between the treatment groups in regard to any demo-
graphic variable. The mean decrease in VAS score from baseline
to ﬁnal visit was 38.5 mm in HC/APAP CR patients versus 26.7
mm in placebo patients (p=0.033). The mean percent decrease
in VAS scores from baseline to ﬁnal visit was 52.5% in HC/APAP
CR compared with 36.0% in placebo (p=0.027). Overall incidence
of adverse events was higher in patients receiving HC/APAP CR
compared with placebo (p≤0.05). The most common adverse
events reported in patients were nausea (21%), constipation
(17%), somnolence (19%), pruritus (12%), and vomiting (10%).
Conclusions: The HC/APAP CR group showed clinically and
statistically signiﬁcant reductions in VAS pain scores compared
with placebo. The safety data demonstrated an AE proﬁle consis-
tent with that of a mu-opioid receptor agonist-containing agent.
Twice-daily dosing of HC/APAP CR tablets may provide an im-
portant and more convenient treatment alternative for patients
with moderate to severe chronic OA pain.
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COMPARISON OF PROPRIOCEPTIVE FUNCTIONS
BETWEEN FUNCTIONAL SQUAT SYSTEM
PROPRIOCEPTIVE EXERCISE AND CLOSED KINETIC
CHAIN EXERCISE IN PATIENTS WITH KNEE
OSTEOARTHRITIS
V. Bayrakci Tunay, G. Baltaci
Hacettepe University, Ankara, Turkey
Purpose: The aim of this study was to compare proprioceptive
function, pain, isokinetic muscle function and walking ability be-
tween functional squat system proprioceptive facilitation exercise
(FSPFE) and closed kinetic chain exercise (CKCE) in patients
with knee osteoarthritis.
Methods: Forty patients with bilateral knee osteoarthritis
were randomly assigned to FSPFE (mean age=48.78 ± 8.46
years,body mass index=26.2 ± 2,81) and CKCE groups (mean
age=53.8 ± 6.33 years,body mass index=28.5 ± 5.56). Both ex-
ercise groups underwent a 4-week program of ﬁve sessions per
week. The FSPFE program included proprioceptive exercises.
CKCE included lunge exercise, mini-squat exercise, Thera-band
exercises for strengthening the pelvic region and isometric exer-
cises in different knee angles for 3 sets of 10 repetitions. Main
outcome measures included isokinetic strength of knee exten-
sors and ﬂexors (ISOMED 2000), physical functioning (Timed
“Up & Go” Test (TUG)) and proprioception test by using Func-
tional Squat System, self-reported questionnaire (WOMAC- the
Western Ontario and McMaster Universities Osteoarthritis Index)
and visual analogue scale (VAS) for he intensity of pain during
activity, at rest and night. All tests were done before and after
the 4-week treatment period.
Results: WOMAC, TUG and proprioception tests results of
CKCE group were; t=5.2, t=5.5 and t=1.02, respectively (p<0.05).
VAS scores during rest, at activity and night for left knee; t=3.3,
t=9.2, t=4 and for right knee; t=2.2, t=6.14, t=3, respectively
(p<0.05). Results of FSPFE group in WOMAC, TUG and proprio-
ception tests were; t=4.6, t=7.8 and t=-3.4, respectively (p<0.05).
VAS scores during rest, at activity and night for left knee; t=3.3,
t=8.5, t=2.4 and for right knee; t=3.3, t=6.4, t=2.6, respectively
(p<0.05). And also signiﬁcant improvements were seen in isoki-
netic strength in both groups (p<0.05). FSPFE group showed
greater improvement in VAS scores during activity and propri-
ception test (p<0.05).
Conclusions: The results of this study showed that both FSPFE
and CKCE were effective in improving joint position sense and
also function, muscle strength and pain. The increase in propri-
oception ability in CKCE patients was not as great as that seen
in FSPFE patients.
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Purpose: To correlate the clinical features and functional status
with the distribution of abnormalities and severity of radiographic
changes in patients with knee OA.
Methods: We studied a group of patients with knee OA (ACR
criteria) from a rheumatology department in Galicia, Spain. A
questionnaire including epidemiologic data, physical examina-
tion, anthropometric measurements, functional status and quality
of life was performed. Radiographic damage was categorized
C208 Poster Presentations
according to Kellgren-Lawrence (K-L) in an AP view X-ray of the
knee. We also recorded the narrowest knee compartment in the
knee with a greater radiographic grade. Pain was evaluated with
a visual analogue scale (VAS) from 0 to 100 mm. Functional
status was evaluated with WOMAC scale and quality of life with
HAQ-DI scale (0-1 low disability, 1-2 moderate and 2-3 severe).
Statistical analysis was accomplished by means of spearman
correlation and a logistic regression model to identify those
variables associated independently with a greater radiographic
grade.
Results: We included 125 patients (102 female/23 male). Mean
age was 65.9 ± 10,1 years. Body mass index (BMI)= 32,2 ±
5,1. Pain referred during the previous week by VAS was 55,5 ±
27,1. They had a total WOMAC of 28,8 ± 18,1, pain-WOMAC
5.6 ± 3,9, stiffness-WOMAC 1,7 ± 1,5, and function WOMAC
21,4 ± 13,9. Radiographic score: 31.2% grade II, 36,8% grade
III and 28,8% grade IV. The medial compartment was the most
commonly affected in 67,7%. Disability was low with an average
of 0.24, only 4% of the patients had moderate or severe disability.
In the univariated analysis we found a signiﬁcant association
between a greater radiographic score and older age (p = 0.001),
greater BMI (p = 0.005), a greater pain-WOMAC (p = 0.001),
greater function-WOMAC (p = 0.001), total-WOMAC (p<0.001)
and HAQ-DI (p<0,001). After adjustment in a logistic regression
model we observed that the variables that were associated
independently with a radiographic grade IV are the BMI (p =
0.046) and HAQ-DI score (p = 0.046). A greater pain, function, and
total-WOMAC were associated with a greater disability according
to HAQ-DI (p = 0.011, p = 0.001 y p = 0.001respectively). We did
not ﬁnd any association between radiographic grade, pain or
disability with the predominant compartment.
Conclusions: Knee osteoarthritis patients have low to moder-
ate grades of pain and disability in our cohort. A greater BMI
and radiographic damage can predict worse functional status
independently of the compartment affected.
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INTRA-ARTICULAR HYALURONIC ACID IS EQUALLY
EFFECTIVE IN DIFFERENT RADIOGRAPHIC STAGES OF
KNEE OSTEOARTHRITIS
E. Onel1, K. Kolsun1, R.D. Altman2
1Ferring Pharmaceuticals, Parsippany, NJ; 2University of
California at Los Angeles, Los Angeles, CA
Purpose: Osteoarthritis (OA) is the most prevalent chronic joint
disorder worldwide, affecting more than 7 million people in the
US and responsible for almost 40 million physician visits per
year. The pain caused by OA affecting the knee can be treated
by multiple modalities, including Intra-Articular Hyaluronic Acid
(IA-HA). Different schools of thought exist regarding when in the
treatment algorithm IA-HA should be administered, with concern
regarding how effective the treatment may be in different radio-
graphic stages of OA. We present a further subset analysis of
a double blind study comparing Synvisc® to Euﬂexxa™ utilizing
disease severity deﬁned by the Kellgren-Lawrence (K-L) radio-
graphic scale to deﬁne the treatment groups in order to see if
the pain caused by OA is more resistant or responsive to IA-HA
treatment when administered at different stages of OA.
Methods: The original study was a prospective, multicenter,
randomized double-blind trial evaluating patients with conﬁrmed
osteoarthritis of the knee and a K-L score of either 2 or 3,
using the WOMAC pain subscale as the primary effectiveness
measure. Both products were administered via three weekly
injections, with follow-up evaluations at weeks 3, 6 and 12.
Acetaminophen was permitted as a rescue medicine and was
quantiﬁed by pill counts. The initial interpretation of the data
showed that the effectiveness of Euﬂexxa™ was not inferior to
that of Synvisc®. Further subset analysis evaluates the K-L scale
to deﬁne the cohorts.
Results: Across the two treatment arms, the 167 patients with
a K-L score of 2 had a mean change on the pain subscale
of the WOMAC of 29.1 as detected by a 100-mm VAS from
the initial to the ﬁnal visit; the 147 patients with a K-L score
of 3 had a change of 30.2. The difference between these two
changes is not statistically signiﬁcant. Interestingly, the K-L 2
patients given Euﬂexxa™ and Synvisc® had very comparable
improvements (28.4 vs 29.9, p=0.66), however the K-L 3 patients
given Euﬂexxa™ had numerically more improvement than those
given Synvisc® (33.6 vs 27.2, p=0.05). Euﬂexxa™ patients also
reported greater satisfaction (3.24 vs 3.05 on a 4 point scale
(p=.08)).
Conclusions: In a double blind study, IA-HA is equally effective
when the Kellgren-Lawrence radiographic grade was 2 or 3.
This was true whether the treatment of choice was Euﬂexxa™
or Synvisc®, although a trend towards greater pain relief and
patient satisfaction was seen with Euﬂexxa™.
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LEVEL OF PAIN COMPARED TO SYNOVIAL
BETA-ENDORFPHIN LEVEL IN OSTEOATHRITIS AND
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Purpose: Avascular necrosis (AVN) develops most frequently in
the femoral head. The disease often causes pain only in the late,
advanced stage. Beta-endorphin (BE), which can be released
both centrally and peripherally is an important indicator of pain
and inﬂammation. The aim of this study was to determine any
difference in the BE level of the synovial ﬂuid at OA patients
compared to the AVN group.
Methods: Synovial ﬂuid was sampled from 10 patients with os-
teoarthritis (OA) of the hip and 10 patients suffering from femoral
head necrosis. The level of beta-endorphin in the synovial ﬂuid
was measured by radioimmunoassay.The 80 % of the AVN group
was Stage IV. and Stage V., 90 % was b or c type. In the OA
group there were two patients with dysplasia of the hip.
Results: The mean of age in the OA group was 63 ± 1.6,
whereas in the AVN group 58 ± 1.8. There was no signiﬁcant
difference between the two groups regarding the age (p=0.45).
The BE-level was 11.08 fmol/ml in the AVN and 6.51 fmol/ml in
the OA group. The difference did not reach p<0.05, but remained
close to it (p=0.09).
On the other hand, comparing the age and the BE level a nega-
tive correlation (R=-0,56) was remarkable, which was signiﬁcant
in the whole population (OA+AVN). This signiﬁcance was mainly
expressed in the AVN group (R=-0.65), whereas the difference in
the OA group is non-signiﬁcant, but it is close to that (R=-0.35).
Conclusions: It is well known from the clinical practice that
the pain-tolerance is higher in the AVN group, which can be
explained by the result that the mean BE value is 70% higher in
case of AVN than in the OA group. Comparing the age and the
BE level a negative correlation was remarkable which might be
to due the impaired activation of suprarenal gland.
